Therapeutic Focus

The MYOS Strategy

Our strategy is to understand the complex genetic and molecular pathways regulating muscle mass and function, as well as other disease mechanisms. Understanding the impact of complex regulatory pathways which act to build and maintain healthy lean muscle is central to our company’s pioneering biotherapeutic discovery science. This research is the foundation of our bionutritional product development. MYOS is developing nutritional products that target specific mechanisms to promote health in ways that cannot be met by other treatments, diets or lifestyle changes. 

Learn More

Clinical Trials and Pre-Clinical Studies

The Effects of Fortetropin on Anabolic and Catabolic Signaling in Skeletal Muscle (MoA Study) / 100%
Effects of Fortetropin™ (MYO-T12®) on Muscle: Clinical effects on lean body mass, fat mass and muscle size; Implications for use and proposed mechanism of action / 100%
The Effects of Fortetropin on blood chemistry and BMI in healthy adult females / 40%
Clinical Study on Fortetropin Dose Response / 10%

Our Partners

RSS Investor Relations and News

Stock Snapshot

MYOS Symbol
NASDAQ Market
Market Cap
Price
Change
Volume